Videos | Chronic Total Occlusion (CTO)
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the ...
October 09, 2017
Technology | Computed Tomography (CT)
Medis has released a new version of its QAngio CT (computed tomography), which can now be launched from the Medis Suite imaging platform. QAngio CT v3.1 provides a detailed analysis of plaque burden analysis of the coronary system with comprehensive results.
October 09, 2017
News | Stent Grafts
October 9, 2017 — The U.S. Food and Drug Administration (FDA) is evaluating recent information regarding Type IIIa and ...
October 09, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
To ensure you continue to receive information most critical to your job, please participate in a survey that will take ...
October 09, 2017
News | Ultrasound Imaging
October 5, 2017 — To provide lifesaving surgical care for sick children in one of the most underserved countries, 13 ...
October 05, 2017
News | Cardiovascular Business
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
October 05, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Cardiovascular Information Systems (CVIS) | Dave Fornell
Consolidation of data in one location to improve efficiency and enable data analytics, as well as smooth integration ...
October 04, 2017
News | Vascular Access
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The technology uses a 4 French catheter system with enhanced visual indicators to create hemodialysis access using an endovascular technique without open surgery.
October 04, 2017News | Pharmaceuticals
October 4, 2017 — MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated cardiomyopathy ...
October 04, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology | Ventricular Assist Devices (VAD)
October 4, 2017 — Medtronic received U.S. Food and Drug Administration (FDA) approval for its HeartWare HVAD System as a ...
October 04, 2017
Feature | Cardiovascular Business
Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm MedAxiom finds that overall, cardiology compensation continues to increase. The company’s fifth annual Cardiovascular Provider Compensation and Production Survey also revealed that one in five cardiologists is over the age of 61, and that overall compensation for private cardiologists is increasing faster than that of their integrated counterparts; the differential in compensation is at its lowest point in five years.
October 03, 2017
October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented the ...
October 03, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News | Cardiovascular Business
October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its ...
October 02, 2017
News | Catheters
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S. Food and ...
October 02, 2017
News | Heart Valve Technology
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in everyday clinical practice. Studying patients with severe symptomatic aortic stenosis at an intermediate, high or extreme risk for open-heart surgery, the FORWARD PRO Clinical Study will evaluate longer-term performance (out to five years) of the next-generation self-expanding transcatheter aortic valve implantation (TAVI) system, which was recently approved for commercial use in Europe and United States.
October 02, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now